Home IOLS IPCL V2 Presbyopic Lens
IPCL Presbyopic image IPCL Sizes IPCL Smart Toric IPCL Central Hole IPCL Aqueous flow

IPCL V2 Presbyopic Lens

For Presbyopic patients aged between 40 – 60.

The patented refractive-diffractive trifocal design ensures good vision at far, intermediate and near distances.

Extensive correction range
Smart Toric – no rotation required
Full lens customisation
IPCL – the customised refractive solution for Presbyopia & Astigmatism.

The IPCL (Implantable Phakic Contact Lens) Presbyopic is the most modern and innovative phakic posterior chamber lens on the market. This advanced technology creates new clinical opportunities for you, enabling you to support a wider patient demographic. It is the ideal solution for presbyopic patients, have astigmatism up to 10 D or thin corneas.

IPCL Presbyopic eliminates the need for reading glasses after 40 years of age. Revolutionising the standards for presbyopic treatments, IPCL is the only phakic lens that can be customised for your patient’s lifestyle and visual needs. The patented design uses a diffractive platform to provide excellent near vision, ensuring excellent light distribution of 50% distance, 30% near and 20% intermediate, with only 8% light loss due to apodisation.

IPCL is a single-piece IOL that offers a tailored presbyopia solution. It gives you the ability to select the additions based on your patient’s current and future needs. Astigmatism correction can also be added with the IPCL Presbyopic Toric.

With over 130,000 implants by over 1,500 surgeons worldwide, IPCL has proven its safety and long-term quality many times over.


A key component in modern refractive clinics.

Spectrum Arrow Excellent optical quality

Spectrum Arrow Superior range of correction

Spectrum Arrow High refractive stability

Spectrum Arrow Posterior chamber positioning

Spectrum Arrow Independent from the cornea

Spectrum Arrow Reversible procedure

The IPCL‘s standard diopter range is: spherical correction +15.0 to -30.0 D and 0.5D to 10.0 D cylindrical correction in 0.5D steps respectively. IPCL V2 Presbyopic has an add of up to +4D. In addition, a custom-made option outside of this range is possible.
IPCL benefits from ‘Smart Toric‘ which has been designed to avoid the problems often associated with conventional toric IOLs; two-step axis marking and alignment. Toric IPCLs are individually manufactured with the axial position of the cylinder of the IPCL adapted to the torus of the cornea. Therefore, IPCL is implanted on 0-180° axis to avoid the need of rotation, reducing the risk of error. Toric IPCL are always positioned horizontally (0-180°).
IPCL is Implantable through a 2.8 mm incision with no special instruments needed. A phakic lens manipulator is all that is required. The user-friendly, single-use disposable injector ensures a short learning curve for lens preparation and loading.
One of the most important prerequisites for a complication-free life with a phakic posterior chamber lens is “sizing“, i.e. selecting the lens diameter that fits the horizontal sulcus width of the eye in such a way that the desired distance (“vault“) between the artificial and the natural lens is created. In this safety critical area, the available lens sizes won‘t force you to compromise. IPCL is available from 11.00 mm to 14.00 mm diameter in 250 μm increments!
The haptic design gives the lens stability with six contact points to the ciliary sulcus. These specially engineered spring haptic pads offer more accurate white-to-white sizing. Angled optic haptics ensure optimal distance (vaulting) from the natural lens.
Manufactured from biocompatible Advanced Hybrid Hydrophilic acrylic material which is free of animal derivatives. IPCL is also around 30% thinner than its competitor. Its modern material does not require any additives to remain stable in size - even in the eye, with proven long-term safety results.
Surgeon benefits:
  • Retains corneal asphericity
  • Range +15D to -30D with Cylinder up to +10D and a presbyopic add of +1.5D to +4D.
  • Ideal for patients who are unsuitable for Lasik or Lasek
  • Central hole to improve aqueous humour flow
  • High patient satisfaction levels
  • Customised calculation and support for you and your patient
Patient benefits:
  • Improved quality of vision
  • Freedom from reading glasses
  • Short procedure time
  • Fast recovery
  • No dry eye
  • Reversible
Technical specifications
Description & Technical Specs

Only IPCL offer this…

Smart toric
Cylinder range: 0.5 to 10 D. The axis position is always individually designed.
Diffractive-refractive trifocal optic
Choice of near vision additions +1.5 D to +3.5 D in 0.5 D steps.
Diopter range:
+15 D to -30 D. Cylinder 0.5 to 10 D
Six Haptics
Provide rotational stability.
Spring haptics
Specially engineered spring haptics provide flexibility and reduce vaulting in case of excessive tension in the sulcus.
Openings at the upper optic rim and the haptic base for even better aqueous humour flow.
Central opening
The central opening is conical on all IPCL Myopic models: (Hyperopic up to +3.5 D SE) the diameter on the posterior surface is larger than on the anterior surface. This reduces light reflections and optimises the aqueous humour flow.
Extensive range of sizes:
11.00mm – 14.00mm in 0.25mm steps.
Adjustable optic diameters
Individually adjustable optic diameters between 6.6 and 7.25mm.
Vault height:
1.2 mm to 1.8 mm
Refractive index:
Back up lens
Always provided for you!
Easy loading
Implantable through 2.8mm.

IPCL (Implantable Phakic Contact Lens) is the latest generation of implantable contact lenses.

IPCL is like a contact lens, soft and flexible and is designed to provide true comfort and flexibility for the best possible fit. The material is extremely compatible and is free from animal derivatives, making it suitable for people whose lifestyle or religion would make some implantable lenses unviable. Manufactured from Advanced Hybrid Hydrophilic (high water content) material, IPCL lenses contain a UV blocker that prevents harmful rays from entering the most sensitive part of your eye.

Each IPCL is manufactured to the individual patient prescription, making it more personalised than any other implantable lens.

The IPCL is folded and inserted through a small surgical opening of 2.8 mm at the edge of the cornea and then positioned behind the iris, in front of the crystalline lens. Vision will have likely improved immediately after treatment, and recovery is usually within a day due to the micro incision used to insert the IPCL (no need for sutures).

The introduction of a hole in the centre of the optic was a revolution in phakic posterior chamber lenses 10 years ago. The benefit of making the otherwise obligatory peripheral iridectomies unnecessary quickly convinced critics, especially since the concern of optical side effects proved to be insignificant.

The IPCL shows that even a revolution can undergo an evolution. The central thickness of the myopic IPCL is less than 80 μm, which reduces edge effects.

In addition, the central opening in the IPCL is conically shaped, with an inner diameter of 420 μm and an outer diameter of 380 μm. This not only results in a funnel effect for aqueous humour flow, it also reduces edge reflections from obliquely incident light.

IPCL lenses have an aspheric optic providing the best image quality, contrast sensitivity and visual sharpness. The IPCL is a solution for myopia (short sightedness), hyperopia (long sightedness), presbyopia (the need for reading glasses, and astigmatism (rugby-shaped eyeball). IPCL could still be an option for patients who have a thin cornea.

With an average length of 12 mm and optic diameter of 6.6 mm, the IPCL is smaller than a 5p coin and of a similar thickness to a strand of hair.

IPCL V2 is a suitable vision correction solution for patients between 21 and 40 years of age. IPCL V2 Presbyopic is suitable for patients aged 40 to 60 years.

Patient selection crucial. The ideal candidate for a phakic intraocular lens is someone who:

  • Is over 21 years of age and has stable refractive error for at least one year
  • Has no contraindications to surgery, i.e. severe dry eye or corneal disease
  • Has realistic expectations about the procedure outcome
  • Can comply with postoperative care instructions (post-op follow-up attendance, no rubbing of eyes)

No. The procedure does not remove any tissue and does not induce dry eye syndrome.

IPCL is not recommended for patients who have undergone LASIK. The LASIK removes tissue and will have induced additional aberrations to the cornea which would compromise visual quality.